Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Chwastiak, L. A. Articles by Lieberman, J. A. Search for Related Content PubMed Citation Articles by Chwastiak, L. A. Articles by Lieberman, J. A. Other Health Services Issues Schizophrenia Spectrum Disorders

Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia

OBJECTIVE: This cross-sectional study aimed to evaluate the interrelationships of psychiatric symptom severity, medical comorbidity, and psychosocial functioning in a sample of patients with schizophrenia by utilizing the baseline data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). METHODS: This study utilized baseline data from a multisite trial of antipsychotic pharmacotherapy, which collected data from 1,460 patients with schizophrenia at more than 50 sites in the United States between 2001 and 2003. Bivariate correlations were used to evaluate associations between schizophrenia symptoms and medical comorbidity, and multivariate regression models were used to determine the independent association between medical comorbidity and psychosocial functioning. RESULTS: Of the 1,424 participants in the study sample, 58 percent had at least one medical condition: 20 percent had hypertension, 11 percent had diabetes mellitus, and 9 percent had four or more medical conditions. Medical comorbidity was associated with poorer neurocognitive functioning and greater depressive symptoms. The number of medical conditions was not associated with more severe schizophrenia symptoms. Both the number of medical conditions and physical health status were only weak correlates of psychosocial functioning. CONCLUSIONS: In this sample of persons with schizophrenia, medical comorbidity was associated with depression and neurocognitive impairment but was a weaker correlate of psychosocial functioning or employment status than psychotic symptoms, depression, and neurocognitive impairment.

This article has been cited by other articles:

				A. B. Rothbard, M. B. Blank, J. P. Staab, T. TenHave, D. S. Young, S. D. Berry, and S. Eachus Previously Undetected Metabolic Syndromes and Infectious Diseases Among Psychiatric Inpatients Psychiatr Serv, April 1, 2009; 60(4): 534 - 537. [Abstract] [Full Text] [PDF]

				S. R. McGurk, K. T. Mueser, T. J. DeRosa, and R. Wolfe Work, Recovery, and Comorbidity in Schizophrenia Schizophr Bull, March 5, 2009; (2009) sbn182v1. [Abstract] [Full Text] [PDF]

				V. H. Srihari, C. Tek, L. A. Chwastiak, S. W. Woods, and J. L. Steiner Best Practices: Surveillance and Management of Diabetes in a CMHC Population Psychiatr Serv, September 1, 2007; 58(9): 1151 - 1153. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us